PT  - JOURNAL ARTICLE
AU  - Johnbosco I. Nwafor
AU  - Ijeoma N. Okedo-Alex
AU  - Arinze C. Ikeotuonye
TI  - Prevalence and predictors of depression, anxiety and stress symptoms among pregnant women during COVID-19-related lockdown in Abakaliki, Nigeria
AID  - 10.1101/2020.08.30.20184697
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.30.20184697
4099  - http://medrxiv.org/content/early/2020/09/02/2020.08.30.20184697.short
4100  - http://medrxiv.org/content/early/2020/09/02/2020.08.30.20184697.full
AB  - Introduction Several studies on COVID-19 and pregnancy have been published recently, but few studies have evaluated the impact of this pandemic on maternal mental health particularly in low-resource setting.Aim To determine the prevalence and predictors of COVID-19-related depression, anxiety and stress symptoms among pregnant women.Materials and methods This was a questionnaire-based cross-sectional study conducted among 456 pregnant women attending prenatal care at Abakaliki, Nigeria during COVID-19-related lockdown. They were screened for psychological morbidities using DASS 21 (Depression, Anxiety and Stress Scale).Results Severe and extremely severe depression were reported in 33 (7.2%) and 29 (6.4%) participants respectively. 15 (3.3%) and 35 (7.7%) women had severe and extremely severe anxiety respectively. 105 (23%) had severe anxiety whereas 76 (16.7%) reported extremely severe stress. Multiparity (2 - 4) and occupations such as trading and farming were predictors of depression whereas grandmultiparity, urban residence and trading were identified as predictors of anxiety and stress.Conclusion Depression, anxiety and stress symptoms were relatively common among pregnant women during COVID-19-related lockdown in Abakaliki, Nigeria. There is a need to integrate screening for depression, anxiety and stress in existing antenatal care programs so as to identify and prevent long term adverse psychological outcome related to COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research and Ethics Committee of Alex Ekwueme Federal University Teaching Hospital,Abakaliki,NigeriaAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request